Cordyceps Sunshine Biotech Holdings (RAJAF) Operating Income (2022 - 2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) recorded quarterly Operating Income of $120448.0 in Q4 2023, up 426.41% quarter-over-quarter from -$36901.0 in Q4 2022, and up 426.41% on a YoY basis from $22881.1 in Q4 2022.

Cordyceps Sunshine Biotech Holdings (RAJAF) Operating Income (2022 - 2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Operating Income history runs 2 years deep, the most recent figure standing at $120448.0 for Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Paranovus Entertainment Technology 12,507.92 Bn 12,507.92 Bn - -
2 Kraft Heinz 27.05 Bn 22.98 Bn 2.22 Bn 1.15 Bn
3 General Mills 17.93 Bn 17.16 Bn 1.37 Bn 524.60 Mn
4 Jbs 13.56 Bn 8.99 Bn 2.32 Bn 484.49 Mn
5 Hormel Foods 13.29 Bn 12.44 Bn 518.51 Mn 217.11 Mn
6 Mccormick 12.45 Bn 12.85 Bn 708.90 Mn 227.50 Mn
7 Magnum Ice Cream 11.94 Bn 11.47 Bn - -
8 J M Smucker 11.83 Bn 11.77 Bn 862.10 Mn 444.50 Mn
9 Smithfield Foods 9.80 Bn 8.73 Bn 511.00 Mn 333.00 Mn
10 Cordyceps Sunshine Biotech Holdings - - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 120,448.00
Dec 31, 2022 -36,901.00